Updates from Myeloma XI trial
Updates from Myeloma XI trial
Ribosomal lesions promote oncogenic mutagenesis
Updated data from the FORTE trial of carfilzomib plus lenalidomide or cyclophosphamide for myeloma
Results from the phase I ICONIC trial
Phase II results of olaparib and abiraterone for mCRPC
Global treatment pattern variations in HCC
Design and interim safety analysis of GeparX trial
International cancer control plans
Economic impact of NGS in non small cell lung cancer
Novel fusion proteins to target PD-L1 in HPV associated cancers
Phase I study results of M7824 for patients with HPV associated cancers
Aspirin combined with acid-reducing medicine offers moderate benefits in patients with Barrett’s oesophagus